Blue Owl Capital Holdings »

Mineralys Therapeutics shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Mineralys Therapeutics shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $590k 200k 2.95

More positions owned by Blue Owl Capital Holdings

Aktis Oncology (AKTS)
Larimar Therapeutics (LRMR)
Engene Holdings
Nuveen Churchill Direct Lend Com Shs (NCDL)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Maplight Therapeutics (MPLT)
Compass Therapeutics (CMPX)
Context Therapeutics (CNTX)
Holley (HLLY)
Eyepoint Com New (EYPT)
Corvus Pharmaceuticals (CRVS)
Conduent Incorporate (CNDT)
Ultragenyx Pharmaceutical (RARE)
Aquestive Therapeutics (AQST)

View all positions for Blue Owl Capital Holdings

Top funds holding Mineralys Therapeutics

Blue Owl Capital Holdings
Group One Trading
Simplex Trading

View all funds holding Mineralys Therapeutics